How Biotin Interferes with Thyroid Tests
Biotin interferes with thyroid function tests by disrupting the streptavidin-biotin binding system used in many immunoassays, causing falsely elevated free T4 and free T3 levels (positive interference in competitive assays) and falsely low TSH levels (negative interference in sandwich assays), creating a laboratory picture that mimics Graves' disease in clinically euthyroid patients. 1
Mechanism of Interference
The interference occurs specifically in assays that use biotinylated antibodies and streptavidin-biotin binding technology. When excess biotin is present in the blood from supplementation, it saturates the streptavidin binding sites, disrupting the intended antibody-antigen interactions 1.
Pattern of Interference by Assay Type
- Competitive immunoassays (free T4, free T3, total T3): Show falsely HIGH results due to biotin blocking the binding sites 2
- Sandwich immunoassays (TSH, thyroglobulin): Show falsely LOW results 2
- Anti-TSH receptor antibodies: Can be falsely detected 2
This creates a characteristic pattern: elevated T4/T3 with suppressed TSH, biochemically suggesting hyperthyroidism or Graves' disease, despite the patient being clinically euthyroid 2.
Clinical Significance and Doses
Research demonstrates that even commonly available over-the-counter biotin doses cause significant interference:
- 10 mg/day (a typical supplement dose): Causes interference in 39% of biotinylated assays versus 0% of non-biotinylated assays 3
- 5 mg/day: Produces interference lasting up to 8 hours after ingestion 4
- 10 mg/day: Interference persists for 1-2 days depending on the platform 4
Maximum interference occurs approximately 2 hours after biotin ingestion 5.
Platform-Specific Vulnerabilities
Not all laboratory platforms are equally affected:
- Roche Cobas systems: Highly susceptible to biotin interference in TSH, free T4, and total T3 assays 6, 5, 4
- Beckman DXI systems: Show significant interference in free T4, free T3, total T3, and thyroglobulin assays 6, 4
- Abbott Architect systems: Generally not affected by biotin interference 5, 4
- Siemens IMMULITE: Shows interference in thyroglobulin assays 5
Identifying Biotin Interference
Key diagnostic clues that suggest biotin interference rather than true hyperthyroidism:
Clinical-biochemical discordance: Laboratory results suggest hyperthyroidism but patient appears clinically euthyroid 2
Pattern inconsistency: Elevated free T3 and free T4 with normal TSH is inconsistent with true hyperthyroidism 6
Total vs. free hormone discrepancy: Significant mismatch between total T3 (falsely elevated if biotin-based assay) and total T4 (unaffected if non-biotin-based) 6
History of biotin supplementation: Often taken for hair, skin, and nail health, or as treatment for metabolic diseases 2
Management Approach
When biotin interference is suspected:
Stop biotin supplementation and wait for washout:
Use alternative testing methods:
Neutralize interference: Some laboratories can neutralize biotin interference following published protocols 1
Critical Pitfalls to Avoid
- Do not initiate antithyroid treatment based solely on discordant biochemistry without clinical correlation 2
- Always ask about supplements: Biotin is widely available over-the-counter and patients may not consider it a "medication" worth mentioning 7
- Be aware of high-dose biotin: Patients with certain metabolic diseases may receive therapeutic biotin doses far exceeding typical supplements 2
- Document biotin use clearly in medical records to prevent future misinterpretation 8
The FDA has issued warnings about biotin interference with laboratory tests, noting it may cause "incorrect test results" particularly affecting cardiovascular and hormone tests 7. This interference represents a significant source of diagnostic error that can lead to unnecessary investigations and inappropriate treatment if not recognized.